Literature DB >> 33970353

Quantification of Myocardial Mitochondrial Membrane Potential Using PET.

Matthieu Pelletier-Galarneau1, Felicitas J Detmer1, Yoann Petibon1, Marc Normandin1, Chao Ma1, Nathaniel M Alpert1, Georges El Fakhri2.   

Abstract

PURPOSE OF REVIEW: To present a method enabling in vivo quantification of tissue membrane potential (ΔΨT), a proxy of mitochondrial membrane potential (ΔΨm), to review the origin and role of ΔΨm, and to highlight potential applications of myocardial ΔΨT imaging. RECENT
FINDINGS: Radiolabelled lipophilic cations have been used for decades to measure ΔΨm in vitro. Using similar compounds labeled with positron emitters and appropriate compartment modeling, this technique now allows in vivo quantification of ΔΨT with positron emission tomography. Studies have confirmed the feasibility of measuring myocardial ΔΨT in both animals and humans. In addition, ΔΨT showed very low variability among healthy subjects, suggesting that this method could allow detection of relatively small pathological changes. In vivo assessment of myocardial ΔΨT provides a new tool to study the pathophysiology of cardiovascular diseases and has the potential to serve as a new biomarker to assess disease stage, prognosis, and response to therapy.

Entities:  

Keywords:  Heart failure; Mitochondria; Mitochondrial membrane potential; Positron emission tomography; Tissue membrane potential; Triphenylphosphonium

Mesh:

Substances:

Year:  2021        PMID: 33970353      PMCID: PMC8443083          DOI: 10.1007/s11886-021-01500-8

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  60 in total

Review 1.  Cooperation of a "reactive oxygen cycle" with the Q cycle and the proton cycle in the respiratory chain--superoxide generating and cycling mechanisms in mitochondria.

Authors:  S S Liu
Journal:  J Bioenerg Biomembr       Date:  1999-08       Impact factor: 2.945

Review 2.  Mitochondrial dysfunction in cardiac disease: ischemia--reperfusion, aging, and heart failure.

Authors:  E J Lesnefsky; S Moghaddas; B Tandler; J Kerner; C L Hoppel
Journal:  J Mol Cell Cardiol       Date:  2001-06       Impact factor: 5.000

Review 3.  Myocardial Protection During Cardiotoxic Chemotherapy.

Authors:  Ronald M Witteles; Xavier Bosch
Journal:  Circulation       Date:  2015-11-10       Impact factor: 29.690

Review 4.  Heart mitochondria: gates of life and death.

Authors:  Asa B Gustafsson; Roberta A Gottlieb
Journal:  Cardiovasc Res       Date:  2007-08-21       Impact factor: 10.787

5.  Binding of doxorubicin to cardiolipin as compared to other anionic phospholipids--an evaluation of electrostatic effects.

Authors:  F A de Wolf
Journal:  Biosci Rep       Date:  1991-10       Impact factor: 3.840

Review 6.  Targeting lipophilic cations to mitochondria.

Authors:  Michael P Murphy
Journal:  Biochim Biophys Acta       Date:  2008-04-08

7.  High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria.

Authors:  S S Korshunov; V P Skulachev; A A Starkov
Journal:  FEBS Lett       Date:  1997-10-13       Impact factor: 4.124

Review 8.  Molecular mechanisms of ischemia-reperfusion injury in brain: pivotal role of the mitochondrial membrane potential in reactive oxygen species generation.

Authors:  Thomas H Sanderson; Christian A Reynolds; Rita Kumar; Karin Przyklenk; Maik Hüttemann
Journal:  Mol Neurobiol       Date:  2012-09-26       Impact factor: 5.590

9.  Doxorubicin Redox Biology: Redox Cycling, Topoisomerase Inhibition, and Oxidative Stress.

Authors:  Hong Zhu; Soumyadeep Sarkar; Laura Scott; Igor Danelisen; Michael A Trush; Zhenquan Jia; Y Robert Li
Journal:  React Oxyg Species (Apex)       Date:  2016

Review 10.  Mitochondrial dysfunction in pathophysiology of heart failure.

Authors:  Bo Zhou; Rong Tian
Journal:  J Clin Invest       Date:  2018-08-20       Impact factor: 14.808

View more
  3 in total

1.  Key Characteristics of Cardiovascular Toxicants.

Authors:  Lars Lind; Jesus A Araujo; Aaron Barchowsky; Scott Belcher; Brian R Berridge; Nipavan Chiamvimonvat; Weihsueh A Chiu; Vincent J Cogliano; Sarah Elmore; Aimen K Farraj; Aldrin V Gomes; Cliona M McHale; Kathleen B Meyer-Tamaki; Nikki Gillum Posnack; Hugo M Vargas; Xi Yang; Lauren Zeise; Changcheng Zhou; Martyn T Smith
Journal:  Environ Health Perspect       Date:  2021-09-24       Impact factor: 9.031

2.  PET imaging of mitochondrial function in acute doxorubicin-induced cardiotoxicity: a proof-of-principle study.

Authors:  Felicitas J Detmer; Nathaniel M Alpert; Sung-Hyun Moon; Maeva Dhaynaut; J Luis Guerrero; Nicolas J Guehl; Fangxu Xing; Pedro Brugarolas; Timothy M Shoup; Marc D Normandin; Matthieu Pelletier-Galarneau; Georges El Fakhri; Yoann Petibon
Journal:  Sci Rep       Date:  2022-04-12       Impact factor: 4.379

Review 3.  Anthracycline-induced cardiotoxicity: From pathobiology to identification of molecular targets for nuclear imaging.

Authors:  Jeremy Jong; James R Pinney; René R Sevag Packard
Journal:  Front Cardiovasc Med       Date:  2022-08-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.